HARMONY BIOSCIENCES HOLDINGS (HRMY)

US4131971040 - Common Stock

33.58  +0.06 (+0.18%)

After market: 33.58 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
305.4M
91.23%
437.9M
43.39%
582.022M
32.91%
726.03M
24.74%
EBITDA
YoY % growth
106.3M
292.25%
143.6M
35.09%
216.389M
50.69%
282.63M
30.61%
EBIT
YoY % growth
87.5M
417.75%
120.2M
37.37%
192.03M
59.76%
250.97M
30.69%
Operating Margin
28.65%27.45%32.99%34.57%
EPS
YoY % growth
0.833.13
277.11%
2.42
-22.68%
2.97
22.59%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
0.63
-4.84%
Revenue
Q2Q % growth
157.78M
32.48%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
43.966M
8.83%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
0.45
-43.04%
0.49-0.04-7.85%
Q3 2023
Q2Q % growth
0.75
-47.92%
0.660.0913.12%
Q2 2023
Q2Q % growth
0.56
43.59%
0.65-0.09-13.20%
Q1 2023
Q2Q % growth
0.66
29.41%
0.480.1837.31%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
168.412M
31.26%
172.44M-4.028M-2.34%
Q3 2023
Q2Q % growth
160.3M
36.77%
151.58M8.72M5.75%
Q2 2023
Q2Q % growth
134.2M
25.42%
144.87M-10.67M-7.37%
Q1 2023
Q2Q % growth
119.1M
39.62%
118.52M580K0.49%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.83% -4.98% -14.39% -16.84%
Revenue0.99% 2.29% -0.3% -0.19%